Maps how DNA folds within cells to reveal structural insights driving genome analysis and disease discovery tools.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
Arima Genomics develops advanced genomic technologies that reveal the three-dimensional architecture of DNA to accelerate biomarker discovery, genome assembly, and disease research. It provides end-to-end lab workflows and analysis solutions—such as Hi-C, HiChIP, and structural variant pipelines—that empower researchers to uncover structural insights across diverse biological systems.
Arima Genomics Funding
Sign up to gain insights into Arima Genomics funding history, including the funding round, time period, and amount raised.
| Financing Round | Date | Amount | Price per share | Valuation |
|---|---|---|---|---|
| Round | Date | Amount | PPS | Valuation |
| Series C | Jun 17, 2025 | 22M | ||
| Series B | Mar 15, 2022 | 7M |
Access the PPS, Valuation details, and a wealth of other data by signing up. Source: Nasdaq Private Market
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Arima Genomics Management Team
Investors
Vectr Ventures
Agilent Technologies
Tech Coast Angels
Genetron Health
Hiaqua Investments
Berkeley Catalyst Fund
Illumina Ventures
Ladder Ventures
Cowin Venture Capital
Co-Win Ventures
Arima Genomics Valuations & Financials
View real-time NPM data on Arima Genomics stock including daily Arima Genomics stock price estimates, valuation history, and historical share price information. Access Arima Genomics financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track Arima Genomics pricing across six independent market signals. Looking for private company due diligence data sources on Arima Genomics? Get in touch to learn more.
Similar Companies
like Arima Genomics
Color
Healthcare & Life Sciences
Physician-ordered genetic testing with comprehensive support, utilizing advanced software and a certified laboratory.
Cityblock
Healthcare & Life Sciences
Tech-driven care provider for communities with complex needs.
Hinge Health
Healthcare & Life Sciences
Digital clinic for back, joint, and muscle pain.
Benchling
Healthcare & Life Sciences
Cloud based platform for research and development in biotechnology.
Lyra
Healthcare & Life Sciences
Digital health startup using technology to connect companies and employees to mental health providers.
Virta Health
Healthcare & Life Sciences
Online specialty medical clinic focused on reversing type 2 diabetes.
Somatus
Healthcare & Life Sciences
Integrated care for patients with or at risk of developing kidney disease.
Cedar
Healthcare & Life Sciences
The tech platform uses modern intelligence to improve healthcare financial experiences for everyone.
FAQ
We have answers
Arima Genomics stock does not trade on public stock exchanges. Arima Genomics stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Arima Genomics stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Arima Genomics Stock does not trade on public stock exchanges. In order to sell Arima Genomics shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Arima Genomics does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view Arima Genomics share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for Arima Genomics stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Arima Genomics stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Arima Genomics stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Arima Genomics is a private company and has not had an IPO. There is currently no Arima Genomics IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to Arima Genomics IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
